Anticipating Industry Arguments: The US Food and Drug Administration’s Authority to Reduce Nicotine Levels in Cigarettes | Zendy

Micah L. Berman | Zendy; Patricia J. Zettler | Zendy; David L. Ashley | Zendy

Open Access

Anticipating Industry Arguments: The US Food and Drug Administration’s Authority to Reduce Nicotine Levels in Cigarettes

Author(s) -

Micah L. Berman,

Patricia J. Zettler,

David L. Ashley

Publication year - 2018

Publication title -

public health reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.202

H-Index - 92

eISSN - 1468-2877

pISSN - 0033-3549

DOI - 10.1177/0033354918776935

Subject(s) - nicotine , transformative learning , food and drug administration , administration (probate law) , tobacco industry , addiction , action (physics) , drug , public health , drug administration , medicine , environmental health , public economics , business , public administration , political science , pharmacology , law , psychology , economics , psychiatry , nursing , pedagogy , physics , quantum mechanics

The US Food and Drug Administration has announced that it is considering lowering nicotine levels in cigarettes to “minimally addictive or nonaddictive levels.” This could be a transformative public health measure, but the tobacco industry is likely to challenge such an action in court. This article reviews some of the key legal arguments that industry is likely to advance and considers possible responses. As we demonstrate, there are strong arguments that the US Food and Drug Administration has the authority to implement a policy to reduce nicotine in cigarettes to nonaddictive levels.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research